MICHAEL F. ELMORE, M.D.; LAWRENCE D. RINK, M.D.; J. PETER RISSING, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: We commend Menda and Gorbach on their approach to the treatment of bacterial endocarditis (Ann Intern Med 78:25-32, 1973). In their 23 cases, 11 of 16 with Staphylococcus aureus had solitary tricuspid involvement, and all 11 had septic pulmonary emboli. Five were treated with cephalothin (12 g/day), and two failed to respond despite the fact that the organisms were sensitive to a minimal inhibitory concentration of less than 1 µg/ml; both patients subsequently responded to clindamycin therapy, but one of the patients required an additional 6-week course of clindamycin after a relapse. We report a similar case.
MICHAEL F. ELMORE, LAWRENCE D. RINK, J. PETER RISSING. Clindamycin, Endocarditis, Hepatotoxicity. Ann Intern Med. 1973;78:779–780. doi: 10.7326/0003-4819-78-5-779_3
Download citation file:
Published: Ann Intern Med. 1973;78(5):779-780.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use